Type 1 Diabetes

Older adults with type 1 or type 2 diabetes who sustain an incident hip fracture have a similar likelihood for a subsequent hip fracture as those without diabetes, according to study data published in Bone.

An FDA committee declined to recommend approval for a once-weekly insulin to improve glycemic control for adults with type 1 diabetes.

The FDA authorized a closed-loop algorithm for an artificial pancreas system for use by people with type 1 diabetes aged 2 years and older, including during pregnancy, according to press release from Cambridge University.

Adults with type 1 diabetes and overweight or obesity prescribed tirzepatide off-label had a reduction in body weight and improvements in HbA1c and continuous glucose monitoring metrics, according to data from a real-world study.

Adults with type 1 diabetes who play sports have less insulin resistance and are less likely to develop metabolic dysfunction-associated steatotic liver disease, according to study findings.

Eating a low-fat vegan diet induced a greater improvement in insulin sensitivity and a larger reduction in total daily insulin dose than a portion-controlled diet for adults with type 1 diabetes, according to study findings.

Semaglutide can be covered under Medicare Part D plans to treat CVD in adults with overweight or obesity, based on new guidelines from CMS.

Hybrid closed-loop insulin delivery systems are more cost-effective for treating type 1 diabetes than immune therapies unless the effects of immune therapies are persistent over a lifetime after one course, according to a speaker.

Pregnant women with type 1 diabetes achieved a higher time in range and had fewer complications with use of a hybrid closed-loop insulin delivery system compared with continuous glucose monitoring alone, according to a speaker.

A once-weekly basal insulin conferred similar changes in HbA1c and time in range as once-daily insulin glargine among adults with type 1 and type 2 diabetes in three phase 2 trials, according to a speaker.